Real-World Safety and Effectiveness of Adalimumab in Patients with Juvenile Idiopathic Arthritis: Results from a Post-Marketing Surveillance in Japan

被引:0
|
作者
Takei, Syuji [1 ]
Iwata, Naomi [2 ]
Kobayashi, Ichiro [3 ,4 ]
Igarashi, Toru [5 ]
Yoshinaga, Yoko [6 ]
Matsubara, Naoko [7 ]
Sunaga, Naomi [8 ]
Ito, Ayumi [7 ]
Yokota, Shumpei [9 ]
机构
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat, Kagoshima, Japan
[2] Aichi Childrens Hlth & Med Ctr, Dept Immunol & Infect Dis, Obu, Japan
[3] Chiba Childrens Hosp, Dept Allergy & Rheumatol, Sapporo, Hokkaido, Japan
[4] Hokkaido Univ, Sapporo, Hokkaido, Japan
[5] Nippon Med Sch, Tokyo, Japan
[6] AbbVie GK, Med Commun, Med, Evidence Solut, Tokyo, Japan
[7] AbbVie GK, Med, Tokyo, Japan
[8] AbbVie GK, Tokyo, Japan
[9] Fuji Toranomon Orthoped Hosp, Gotemba, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2382
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
    Hayase, Naomi
    Yamada, Mariko
    Kaneko, Shuhei
    Watanabe, Yoko
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (06) : 660 - 673
  • [22] Real-world effectiveness and safety of golimumab in patients with ulcerative colitis: 52-weeks of post-marketing surveillance data in Japan
    Nakamura, S.
    Asano, T.
    Tanaka, Y.
    Sugimoto, K.
    Yoshigoe, S.
    Suzuki, Y.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I439 - I441
  • [23] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
    Naomi Hayase
    Mariko Yamada
    Shuhei Kaneko
    Yoko Watanabe
    [J]. Clinical and Experimental Nephrology, 2021, 25 : 660 - 673
  • [24] Efficacy and safety of adalimumab treatment in psoriasis with psoriatic arthritis: Result from post-marketing surveillance in Japan
    Asahina, A.
    Toril, H.
    Ohtsuki, M.
    Sawa, J.
    Yamaguchi, Y.
    Nakagawa, H.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S90 - S90
  • [25] Safety and Efficacy of Real-World Use of Everolimus for Kidney Transplant Patients: Post-Marketing Surveillance in Japan.
    Harada, H.
    Watarai, Y.
    Uchida, J.
    Kamisawa, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 675 - 675
  • [26] Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study)
    Isao Sakaida
    Shuji Terai
    Masayuki Kurosaki
    Mitsuru Okada
    Takahiro Hirano
    Yasuhiko Fukuta
    [J]. Journal of Gastroenterology, 2020, 55 : 800 - 810
  • [27] Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study)
    Sakaida, Isao
    Terai, Shuji
    Kurosaki, Masayuki
    Okada, Mitsuru
    Hirano, Takahiro
    Fukuta, Yasuhiko
    [J]. JOURNAL OF GASTROENTEROLOGY, 2020, 55 (08) : 800 - 810
  • [28] Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
    Hide, Michihiro
    Fukunaga, Atsushi
    Suzuki, Takayuki
    Nakamura, Noriko
    Kimura, Mine
    Sasajima, Takayoshi
    Kiriyama, Junna
    Igarashi, Atsuyuki
    [J]. ALLERGOLOGY INTERNATIONAL, 2023, 72 (02) : 286 - 296
  • [29] Real-world safety and effectiveness of intravenous fomepizole in patients with ethylene glycol and methanol poisoning in Japan: results of a 7-year post-marketing surveillance study
    Yoshioka, Toshiharu
    Koyanagi, Momoha
    Yoshida, Naoki
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
  • [30] Real-world safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 401 Japanese patients: results from an interim analysis of post-marketing surveillance
    Tachibana, Yosuke
    Takasaki, Sakura
    Hoshino, Misuzu
    Makioka, Haruki
    Jin, Mingshou
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (02) : 153 - 162